Poster #47| Volume 153, ISSUE 3, e20, June 2019

Download started.


A cost-effectiveness analysis of universal genetic testing for common hereditary cancer mutations in women compared with family-history based testing

      Objectives: Identifying patients who would benefit from hereditary cancer genetic testing by family history alone can miss a significant portion of both BRCA and Lynch mutation carriers. The purpose of this study is to determine whether population-based testing with a common hereditary cancer panel in all women regardless of family history is a cost-effective cancer prevention strategy.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Gynecologic Oncology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect